Search for: "Rachel Sachs" Results 1 - 20 of 126
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
31 May 2016, 4:44 pm by Camilla Alexandra Hrdy
If anyone is looking for a clear and comprehensive review of the ways in which patents can distort investment in innovation, as well as a summary of the literature on incentives "beyond IP", I highly recommend Rachel Sachs' new article Prizing Insurance: Prescription Drug Insurance as Innovation Incentive, forthcoming in the Harvard Journal of Law & Technology. [read post]
5 May 2021, 12:45 pm by Neil Schoenherr
Sachs Rachel Sachs, associate professor of law at Washington University School of Law in St. [read post]
7 Feb 2022, 9:59 am by Neil Schoenherr
Sachs Rachel Sachs, the Treiman Professor of Law at Washington University in St. [read post]
27 Jul 2015, 9:39 am by Lisa Larrimore Ouellette
In Innovation Law and Policy: Preserving the Future of Personalized Medicine, Rachel Sachs (Petrie-Flom Fellow at Harvard Law) examines the intersection of IP with FDA regulation and health law, joining a growing body of scholarship that seeks to contextualize IP in a broader economic context. [read post]
9 Jun 2016, 3:30 am by Amy Monahan
Rachel Sachs, Prizing Insurance: Prescription Drug Insurance as Innovation Incentive, 30 Harv. [read post]
12 Apr 2015, 11:00 pm by sbc32
The Petrie-Flom Center, Harvard Law School Rachel E. [read post]
22 Jul 2022, 2:00 am by Katharine Van Tassel
Nicholson Price II (University of Michigan), Rachel Sachs (Washington University in Saint Louis), Jacob S. [read post]
10 May 2022, 2:00 am by Katharine Van Tassel
Mello (Stanford University), Trish Riley (affiliation not provided), Rachel Sachs (Washington University in Saint Louis), The Role of State Attorneys General in Improving Prescription Drug Affordability, S. [read post]
15 May 2023, 2:00 am by Katharine Van Tassel
Rai (Duke University), Rachel Sachs (Washington University in Saint Louis), W. [read post]
12 Oct 2021, 2:00 am by Katharine Van Tassel
Rachel Sachs (Washington University in Saint Louis) Lisa Larrimore Ouellette (Stanford University) W. [read post]
30 Jul 2021, 2:00 am by Katharine Van Tassel
Rachel Sachs (Washington University in Saint Louis), Encouraging Interagency Collaboration: Learning from COVID-19, J. [read post]
20 Mar 2021, 2:00 am by Katharine Van Tassel
Nicholson Price II (University of Michigan), Rachel Sachs (Washington University in Saint Louis), Rebecca S. [read post]
3 Nov 2021, 2:00 am by mes286
Northeastern University School of Law – Rachel Sachs, Treiman Professor of Law, Washington University in St. [read post]
3 Nov 2021, 2:00 am by mes286
Northeastern University School of Law – Rachel Sachs, Treiman Professor of Law, Washington University in St. [read post]
1 Feb 2019, 9:56 am by Neil Schoenherr
Sachs“The new proposal aims to eliminate rebates from pharmaceutical companies to pharmacy benefit managers (PBMs) in Medicare Part D and in Medicaid managed care organizations,” said Rachel Sachs, associate professor of law in the School of Law. [read post]
12 Jan 2017, 7:30 am by Neil Schoenherr
Despite announcing in his first press conference that he would deal with a pharmaceutical industry “getting away with murder,” President-elect Donald Trump doesn’t seem to have a clear path for how he will reduce drug prices, said Rachel Sachs, associate professor of law at Washington University in St. [read post]
13 Feb 2018, 6:44 am by Neil Schoenherr
“Gone are some of President Trump’s older arguments that Medicare should negotiate drug prices, or that drug importation should be permitted more widely,” said Rachel Sachs, associate professor of law in the School of Law. [read post]